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Assessment of a possible connection between milk consumption and the develop-
ment of type 2 diabetes mellitus 
 
Updated BfR Opinion No. 017/2013 of 2 July 2013* 
 
The Federal Institute for Risk Assessment (BfR) is publishing this opinion on a potential con-
nection between the rising consumption of milk and dairy products and the development of 
type 2 diabetes mellitus. Individual observers have expressed the hypothesis that the rise in 
diabetes is due to the increased consumption of milk and dairy products. The theory is that 
above all the amino acid leucine, which is a natural ingredient of milk, plays a particular role 
by activating the body's own signal systems.  
 
The BfR has evaluated the available scientific studies and comes to the conclusion that there 
is no evidence for a positive relationship between milk consumption and type 2 diabetes mel-
litus. There are, for example, no scientifically valid studies on humans that support this the-
ory. Numerous epidemiological studies refute a positive connection between milk consump-
tion and type 2 diabetes mellitus. What is rather the case is that favourable effects are be-
lieved to exist with regard to the development of type 2 diabetes mellitus. 
 
Restricting consumption of milk and dairy products is not a meaningful strategy to prevent 
diabetes. Milk and dairy products should be part and parcel of a balanced diet, with prefer-
ence generally being given to low-fat products.  
 
 
 
 
BfR risk profile: 
Milk consumption and diabetes (Opinion No. 17/2013) 
A Affected group General population 
B 
Probability of health 
impairment due to the 
consumption of milk 
It is not assumed that a positive relationship exists between milk consumption and type 2 diabetes mellitus 
C 
Severity of health impair-
ment due to the consump-
tion of milk 
No  
Impairment 
Slight 
impairment 
[reversible/irreversible] 
Moderate 
impairment 
[reversible/irreversible] 
Serious 
impairment 
[reversible/irreversible] 
D Robustness of the avail-able data 
High:
The most important data are 
available and are free of con-
tradictions
Average: 
some important data is 
missing or is contradictory 
Low:  
much important data is missing or 
is contradictory 
E Possibility of consumer control  
Control not 
necessary 
Can be controlled by 
taking precautionary 
measures 
Can be controlled by 
refraining from 
consumption 
Not controllable 
 
Text fields with dark blue background highlighting characterise the properties of the risk assessed in this opinion 
(for more detailed information, please refer to the text in BfR Opinion No. [No./Year] dated [Day/Month/Year). 
 
 
Explanations 
 
The risk profile is designed to visualise the risk outlined in the BfR Opinion. It is not designed to permit risk comparisons. The risk profile should 
only be read in conjunction with the opinion. 
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* Diese aktualisierte Stellungnahme ersetzt die Stellungnahme     Seite 1 von 5 
des BfR vom  4. Januar 2012 
 www.bfr.bund.de 
Bundesinstitut für Risikobewertung 
 
 
1  Subject of the assessment 
 
The Federal Institute for Risk Assessment (BfR) is publishing this opinion on a potential con-
nection between the rising consumption of milk and dairy products and the development of 
type 2 diabetes mellitus. It is doing so in response to the hypothesis expressed by individual 
observers that high protein consumption, in particular of the essential amino acid leucine, 
through the consumption of milk and dairy products is associated with an increased risk of 
the development of type 2 diabetes mellitus. 
 
2   Findings 
The data on a possible connection between milk consumption and type 2 diabetes mellitus is 
contradictory, but the majority of studies show that milk and dairy products have a protective 
effect with regard to the development of type 2 diabetes and metabolic syndrome. Metabolic 
syndrome is characterised by, among other things, insulin resistance and is seen as a risk 
factor for coronary heart diseases and other illnesses. Reducing the consumption of dairy 
products is not considered a meaningful strategy for diabetes prevention.(Low-fat) Milk and 
dairy products should be part and parcel of a balanced diet. 
 
3   Statement of reasons 
Individual hypotheses on the development of type 2 diabetes mellitus due to the consumption 
of milk and dairy products have no scientific basis. There are, for example, no scientifically 
valid studies on humans that support this theory. 
 
Numerous epidemiological studies refute a positive relationship between milk consumption 
and type 2 diabetes mellitus. A meta-analysis published in 2011 showed an inverse associa-
tion between daily consumption of dairy products, above all low-fat dairy products, and type 2 
diabetes mellitus. Milk and dairy products can therefore be assumed to have positive effects 
with regard to the development of type 2 diabetes mellitus (Tong et al., 2011). 
 
4   Risk assessment 
Due to their high concentration of saturated fatty acids, milk and dairy products have occa-
sionally been viewed critically in the past with regard to the development of overweight and 
cardiovascular diseases. However, epidemiological studies have ruled out a negative effect 
of dairy products on the development of these diseases (Snijder et al., 2007, Soedamah-
Muthu et al., 2011). On the contrary: low-fat dairy products in particular have even been 
found to reduce the risk of metabolic syndrome and cardiovascular disease (Pereira et al., 
2002, Elwood et al., 2007, Azadbakht et al., 2005, Elwood et al., 2008). They are also con-
sidered to reduce the risk of type 2 diabetes mellitus (Ferland et al., 2011, Margolis et al., 
2011, Wennersberg et al., 2009). 
 
5   Discussion 
The assumed favourable effects of dairy products with regard to the risk of developing type 2 
diabetes mellitus can partly be attributed to the effect on factors that promote the disease 
such as body weight (Hu, 2008) and glucose homeostasis (Tremblay and Gilbert, 2009). Cer-
tain ingredients of milk, such as calcium and milk protein, have been discussed as having 
positive effects on body weight and blood pressure (Tremblay and Gilbert, 2009). 
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However, the findings of prospective cohort studies do not indicate any role of dairy products 
in weight control (Hu, 2008, Rajpathak et al., 2006). The "Dietary Approaches to Stop Hyper-
tension (DASH)" study established a connection between the consumption of 3 portions of 
low-fat milk and other dairy products daily and lower blood pressure, showing this effect to 
almost twice that achieved by a diet low on dairy products but containing a high amount of 
fruit and vegetables (Sacks et al., 2001). 
 
Milk proteins  like those in whey can have insulinotropic properties and improve glucose tol-
erance due to their relatively low glycemic load (GL) (King, 2005). Moreover, other ingredi-
ents in dairy products, including medium-chain fatty acids, calcium, vitamin D and magne-
sium can reduce insulin resistance (Tremblay and Gilbert, 2009, Larsson et al., 2007, Pittas 
et al., 2007, Azadbakht et al., 2005). 
 
While the consumption of dairy products can also be associated with a lower GL, some stud-
ies found a GL-independent association between the consumption of dairy products and type 
2 diabetes mellitus (Liu et al.,2006, Choi et al., 2005). 
 
Individual observers have expressed the hypothesis that branched-chain essential amino 
acids are responsible for the development of diabetes because they activate the body's own 
signal systems. These amino acids include leucine, for example, which occurs naturally in 
milk. 
 
Amino acids activate the enzyme "mammalian target of rapamycin" (mTOR) enzyme (Dennis 
et al., 2011). The mTOR enzyme is part of the mTOR protein complex 1 (mTORC1), which 
integrates different signal paths of growth factors, the energy household and the oxygen 
concentration of the cell, regulating the translation of proteins and thereby controlling cell 
growth and cell cycle. The mTORC1 complex promotes nutrient-induced insulin resistance 
by downward regulation of the insulin receptor substrate proteins (Fraenkel et al., 2008). 
However, no scientifically valid studies that provide evidence of activation of mTORC1 by 
dairy products are known. 
 
Milk consumption stimulates insulin-like-growth-factor 1 (IGF-1) and activates the incretin, 
glucose-dependent insulinotropic polypeptide (GIP) in dependence on milk protein (Nilsson 
et al., 2007). Activation of GIP to stimulate insulin release was observed in particular follow-
ing the administration of milk proteins. This resulted in a reduced postprandial glucose rise 
(Frid et al., 2005). This mechanism is being discussed as the factor behind the protective 
effect of milk and dairy products with regard to the development of type 2 diabetes mellitus. It 
is therefore not possible to understand how the stimulation of GIP caused by amino acids is 
supposed to lead to poorer blood sugar regulation. 
 
An increase in protein consumption has been observed in Germany since the 1950s, which 
means that leucine is also being consumed in larger quantities. During the same period, ho-
wever, calorie intake and the intake of macronutrients, in particular fat, have also increased. 
There is no evidence whatsoever that the rise in leucine intake has led to an increased inci-
dence of type 2 diabetes mellitus. What is rather seen as the cause is the massive increase 
in overweight and obesity as the expression of a dysregulated energy balance. There are no 
epidemiological studies or intervention studies showing a statistically validated relationship 
between leucine intake and diabetes mellitus. 
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6   Framework for action / Measures 
The BfR does not see any need for action. 
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